Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Pediatric Immunology · STAT3 Gain-of-Function Syndrome

Building Your Care Team

At a Glance

Children with STAT3-GOF syndrome often need a coordinated team led by a pediatric immunologist, with specialists for blood, gastrointestinal, endocrine, lung, and infection concerns. Bringing complete records and arranging shared communication can make care safer and more consistent.

Because STAT3-GOF syndrome is an ultra-rare, multisystem disorder, it cannot be managed by a single doctor. The “stuck switch” in your child’s immune system affects many different organs, meaning your child will likely need a team of specialists who talk to one another regularly [1][2].

Navigating this complex web of care can feel like a second job. Your goal is to build a “medical home” where one lead specialist—usually a pediatric immunologist—helps coordinate the efforts of the entire team to ensure your child is treated as a whole person, not just a collection of symptoms [3].

The Core Care Team

While your child’s specific needs will guide who you see, many families with STAT3-GOF will eventually work with these specialists:

  • Pediatric Immunologist: This specialist should lead the team. They focus on the underlying immune dysregulation and will likely be the one prescribing and monitoring targeted therapies like JAK inhibitors [1][4].
  • Hematologist: Because autoimmune blood disorders (like low platelets or red blood cells) affect 67% of patients in studied cohorts, a hematologist is often needed for managing blood counts and monitoring for lymphoproliferation [1].
  • Gastroenterologist (GI): Important if your child has chronic diarrhea, stomach pain, or difficulty gaining weight. They monitor for autoimmune enteropathy (inflammation in the gut) [5][6].
  • Endocrinologist: This specialist monitors growth, thyroid function, and the risk of early-onset diabetes, which are common in STAT3-GOF [7][8].
  • Pulmonologist: They monitor lung health, checking for “silent” inflammation or scarring (interstitial lung disease) that might not be obvious during a regular check-up [9][1].
  • Infectious Disease (ID) Specialist: Because both the disease and the treatments can increase the risk of unusual infections, an ID doctor helps create a plan for preventing and treating illnesses [1][4].
  • Other Essential Support: A Genetic Counselor, Clinical Pharmacist, Dietitian, Social Worker, and a Primary Care Clinician are important resources for a comprehensive care plan [2].

Preparing for the First Consult

When you meet a new specialist, you are often the person who knows the most about your child’s specific history. To make the most of these visits, you should bring a physical or digital “care binder” containing the following reports:

  1. The Full Genetic Report: This is the most important document. It must include the exact protein change (e.g., STAT3 p.T716M). Note that whether the variant was inherited or “de novo” may only be known if parental testing has been completed [10][11].
  2. Recent Lab Work: Bring the last 3–6 months of Complete Blood Counts (CBC), immunoglobulin levels, and lymphocyte subset panels (especially results showing double-negative T cells) [1][12].
  3. Growth Charts: A printout of your child’s height and weight over time. A “flatline” or drop in growth is a key clinical sign of STAT3-GOF [8][13].
  4. Pathology and Imaging: If your child has had biopsies (of the gut, skin, or lymph nodes) or CT scans of the lungs, bring the formal written reports and, if possible, the actual images on a CD or digital link [6][3].
  5. A Medication Timeline: A list of every treatment your child has tried, the dosage, how long they took it, and whether it helped or caused side effects [14].

Coordinating the “Silos”

In many healthcare systems, doctors work in “silos,” meaning the GI doctor might not know what the pulmonologist is doing. As a parent, you may need to prompt this communication.

Ask your lead immunologist if they can host a “multidisciplinary case conference”—a meeting (often virtual) where all your child’s specialists discuss the treatment plan together [2][15]. This ensures that a treatment for one symptom (like a steroid for lung issues) doesn’t accidentally make another issue (like a gut infection or growth delay) worse. Establishing this shared-care plan early can significantly improve coordination and reduce the stress on your family [1][16].

Common questions in this guide

Who should coordinate my child’s STAT3-GOF care?
A pediatric immunologist often serves as the lead clinician because STAT3-GOF affects the immune system and several organs. This person can help connect hematology, gastrointestinal, endocrine, lung, infectious disease, primary care, and support services.
What specialists might a child with STAT3-GOF need?
Depending on the child’s symptoms, the team may include a hematologist, gastroenterologist, endocrinologist, pulmonologist, and infectious disease specialist. A genetic counselor, clinical pharmacist, dietitian, social worker, and primary care clinician can also support the care plan.
What records should I bring to my child’s first specialist visit?
Bring the complete genetic report, including the exact protein change and whether the variant is inherited or new if parental testing has been done. Also bring recent blood counts and immune tests, growth charts, pathology or imaging reports and images, and a timeline of medicines, doses, benefits, and side effects.
How can my child’s specialists avoid giving conflicting advice?
Ask the lead immunologist to coordinate a shared-care plan and, when helpful, arrange a multidisciplinary case conference. Having specialists discuss treatments together can help balance issues such as infection risk, lung inflammation, gut disease, and growth concerns.
What should I ask about JAK inhibitor treatment for my child?
Ask whether the team has experience using JAK inhibitors in children with STAT3-GOF or similar immune disorders. Discuss how treatment will be monitored, how infection concerns will be handled, and whom to contact with questions between appointments.

Get notified when new evidence is published on STAT3-related early-onset multisystem autoimmune disease.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Monogenic early-onset lymphoproliferation and autoimmunity: Natural history of STAT3 gain-of-function syndrome.

    Leiding JW, Vogel TP, Santarlas VGJ, et al.

    The Journal of allergy and clinical immunology 2023; (151(4)):1081-1095 doi:10.1016/j.jaci.2022.09.002.

    PMID: 36228738
  2. 2

    Ocular manifestations of STAT3 gain-of-function syndrome: A case of papillitis, retinitis, and retinal vasculitis.

    Hwang J, Situ B, Naderi A, Lee SY

    American journal of ophthalmology case reports 2026; (42()):102540 doi:10.1016/j.ajoc.2026.102540.

    PMID: 41778090
  3. 3

    STAT3 gain-of-function mutation presenting with adult-onset recurrent abdominal pain, fever and lymphadenopathy, managed by JAK inhibitor therapy.

    Desoki R, Barreda S, Khwaja S, Parkes M

    BMJ case reports 2026; (19(1)) doi:10.1136/bcr-2025-271007.

    PMID: 41554622
  4. 4

    Janus Kinase Inhibitors in Treatment of Primary Immune Regulatory Disorders.

    Alsaati NF, Satter LF

    The journal of allergy and clinical immunology. In practice 2026; (14(7)):1491-1503 doi:10.1016/j.jaip.2026.05.019.

    PMID: 42409456
  5. 5

    Clinical Aspects of STAT3 Gain-of-Function Germline Mutations: A Systematic Review.

    Fabre A, Marchal S, Barlogis V, et al.

    The journal of allergy and clinical immunology. In practice 2019; (7(6)):1958-1969.e9 doi:10.1016/j.jaip.2019.02.018.

    PMID: 30825606
  6. 6

    Reduction in mucosal phosphorylated STAT3 under therapy with JAK inhibitor in STAT3 gain of function mutation - a case study.

    Oberli R, Mookhoek A, Denier D, et al.

    Virchows Archiv : an international journal of pathology 2026; doi:10.1007/s00428-026-04409-1.

    PMID: 41555056
  7. 7

    Endocrinopathies in children with inborn errors of immunity: a single-center experience.

    Buyukyilmaz G, Toksoy Adiguzel K, Kocaay P, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2025; (38(7)):735-742 doi:10.1515/jpem-2024-0593.

    PMID: 40270454
  8. 8

    Short Stature in a Boy with Multiple Early-Onset Autoimmune Conditions due to a STAT3 Activating Mutation: Could Intracellular Growth Hormone Signalling Be Compromised?
.

    Sediva H, Dusatkova P, Kanderova V, et al.

    Hormone research in paediatrics 2017; (88(2)):160-166 doi:10.1159/000456544.

    PMID: 28253502
  9. 9

    Pulmonary Histopathology Findings in Patients With STAT3 Gain of Function Syndrome.

    Cortes-Santiago N, Forbes L, Vogel TP, et al.

    Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society 2021; (24(3)):227-234 doi:10.1177/1093526620980615.

    PMID: 33651637
  10. 10

    Disease-causing STAT3 variants can be discriminated by a functional flow cytometry test.

    Esteve-Sole A, Freeman AF, Hsu A, et al.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2026; (37(2)):e70300 doi:10.1111/pai.70300.

    PMID: 41644831
  11. 11

    From CVID to PIRD: Genetic Testing Leading to Signal Transducer and Activator of Transcription 3 Gain-of-Function Diagnosis and Directed Therapy.

    Lang A, Agharahimi A, Vogel TP, et al.

    The journal of allergy and clinical immunology. In practice 2026; (14(7)):1506-1514 doi:10.1016/j.jaip.2026.03.041.

    PMID: 41999916
  12. 12

    Dominant-Negative Versus Gain-of-Function STAT3 Defects: A Systematic Review on Epidemiological, Clinical, Immunological, and Molecular Aspects.

    Hajialigol A, Azizi G, Seifi Alan M, et al.

    The journal of allergy and clinical immunology. In practice 2025; (13(6)):1440-1448.e4 doi:10.1016/j.jaip.2025.04.014.

    PMID: 40246075
  13. 13

    Activating mutations of STAT3: Impact on human growth.

    Gutiérrez M

    Molecular and cellular endocrinology 2020; (518()):110979 doi:10.1016/j.mce.2020.110979.

    PMID: 32818584
  14. 14

    JAK inhibitor treatment for inborn errors of JAK/STAT signaling: An ESID/EBMT-IEWP retrospective study.

    Fischer M, Olbrich P, Hadjadj J, et al.

    The Journal of allergy and clinical immunology 2024; (153(1)):275-286.e18 doi:10.1016/j.jaci.2023.10.018.

    PMID: 37935260
  15. 15

    Guidance on JAK inhibitor treatment for inborn errors of JAK-STAT signaling, 2026: International consensus statement on behalf of the European Society for Immunodeficiencies/European Society for Blood and Marrow Transplantation-Inborn Errors Working Party and ERN-RITA.

    Olbrich P, Fischer M, Deyà-Martinez Á, et al.

    The Journal of allergy and clinical immunology 2026; (158(2)):598-609.e5 doi:10.1016/j.jaci.2026.05.005.

    PMID: 42203177
  16. 16

    STAT1 and STAT3 mutations: important lessons for clinical immunologists.

    Olbrich P, Freeman AF

    Expert review of clinical immunology 2018; (14(12)):1029-1041 doi:10.1080/1744666X.2018.1531704.

    PMID: 30280610

This page is for informational purposes only and does not constitute medical advice. It offers general care-coordination information for children with STAT3-GOF syndrome; your child’s clinicians should guide decisions about tests, medicines, and referrals.

Guide contents STAT3-related early-onset multisystem autoimmune disease
Research & Literature
04 Treating the "Stuck Switch" 06 The Path Forward